TSE (transmissible spongiform encephalopathy) diagnostics top agenda amid new infectivity evidence
This article was originally published in Clinica
Executive Summary
There is renewed pressure to find a reliable ante-mortem diagnostic test for transmissible spongiform encephalopathies (TSEs), after UK researchers last week reported the "first conclusive evidence of significant levels of infectivity in blood in a naturally occurring TSE". In light of the evidence, the Department of Health has announced that it is preparing to issue new guidelines to further reduce the risk of secondary transmission of the human TSE, variant Creutzfeldt-Jakob disease (vCJD).
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.